SCHMID Group N.V. Class A Ordinary Shares (SHMD)

FairStock Score: 21/100 — RISKY

Key Financials

Current Price$2.71
Market Cap$349M
P/E Ratio-0.99
ROE—%
Dividend Yield0%
SectorIndustrials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a value investor, I start with demonstrated earning power and a margin of safety. SCHMID Group is a $349.2 million market-cap specialty industrial machinery company that sells equipment and process solutions for electronics, photovoltaics, glass, and energy systems, with 676 employees and an international footprint. At the close on 2026-10-13, the shares were $3.83, near the low end of their 52-week range of $2.93 to $10.65. That low price may attract attention, but the numbers do not yet show a bargain. The FairStock P/E is -1.40, meaning there are no positive trailing earnings to value. FairStock's ROCE is -2.78%, Piotroski F-Score is 2/9, and Altman Z-Score is 1.20 — a set of readings that points to weak profitability and possible financial stress. P/B, D/E, ROE, revenue growth, and profit growth are all unavailable, and the Lynch category is none because there are only 0 years of filed results, when three are needed. Without a multi-year record, I cannot judge a durable competitive moat, pricing power, or capital allocation. The absence of a dividend is not a flaw by itself, but it offers no cash return while the business is unprofitable. FairStock Score 21/100 reinforces that this is a speculative turnaround story rather than a Graham-style value opportunity. The beta of -0.36 is unusual but does not substitute for earning power. I would need to see filed evidence of positive returns, a stronger balance sheet, and consistent results before calling this investment-grade. Until then, the price reflects hope, not proven value.

In plain English: SCHMID Group makes machines and process equipment used to produce electronics, solar panels, glass, and energy systems. The business looks weak right now: it is losing money, has weak financial-health scores, pays no dividend, and does not yet have enough filed history to judge a track record. At $3.83, the price is not supported by current profits, so it looks expensive relative to what the company earns today.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer